NCT06422039View on ClinicalTrials.gov

Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

June 15, 2024

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

HRS-7535（D）Tablets

One HRS-7535（D）Tablet is administered to healthy subjects.

DRUG

HRS-7535（C）Tablets

Two HRS-7535（C）Tablets is administered to healthy subjects.

Trial Locations (1)

230601

The Second Hospital of Anhui Medical Uniersity, Hefei

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06422039 - Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects | Biotech Hunter | Biotech Hunter